Literature DB >> 9462258

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.

P J van Diest1, P van Dam, S C Henzen-Logmans, E Berns, M E van der Burg, J Green, I Vergote.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9462258      PMCID： PMC500257          DOI： 10.1136/jcp.50.10.801

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  18 in total

1.  Quality control in immunocytochemistry: experiences with the oestrogen receptor assay.

Authors:  F T Bosman; A F de Goeij; M Rousch
Journal:  J Clin Pathol       Date:  1992-02       Impact factor: 3.411

2.  Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry.

Authors:  J C Fleege; P J van Diest; J P Baak
Journal:  Lab Invest       Date:  1990-08       Impact factor: 5.662

3.  Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus.

Authors:  W Polkowski; G A Meijer; J P Baak; F J ten Kate; H Obertop; G J Offerhaus; J J van Lanschot
Journal:  Anal Quant Cytol Histol       Date:  1997-06       Impact factor: 0.302

4.  Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen.

Authors:  D J Gaskell; R A Hawkins; K Sangsterl; U Chetty; A P Forrest
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

5.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

6.  Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'.

Authors:  H J Gundersen; R Osterby
Journal:  J Microsc       Date:  1981-01       Impact factor: 1.758

7.  Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.

Authors:  J P Baak; D Chin; P J van Diest; R Ortiz; P Matze-Cok; S S Bacus
Journal:  Lab Invest       Date:  1991-02       Impact factor: 5.662

8.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

9.  Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation.

Authors:  J C Fleege; P J van Diest; J P Baak
Journal:  Anal Quant Cytol Histol       Date:  1993-08       Impact factor: 0.302

Review 10.  Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology?

Authors:  P Fritz; X Wu; H Tuczek; H Multhaupt; P Schwarzmann
Journal:  Pathologica       Date:  1995-06
View more
  65 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Comparison of different scoring systems for immunohistochemical staining.

Authors:  E J Adams; J A Green; A H Clark; J H Youngson
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

Review 3.  Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer.

Authors:  Eugenia V Broude; Balázs Győrffy; Alexander A Chumanevich; Mengqian Chen; Martina S J McDermott; Michael Shtutman; James F Catroppo; Igor B Roninson
Journal:  Curr Cancer Drug Targets       Date:  2015       Impact factor: 3.428

4.  Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.

Authors:  Marios A Gavrielides; Brandon D Gallas; Petra Lenz; Aldo Badano; Stephen M Hewitt
Journal:  Arch Pathol Lab Med       Date:  2011-02       Impact factor: 5.534

5.  Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries.

Authors:  A Rhodes; B Jasani; A J Balaton; K D Miller
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

6.  Evaluation environment for digital and analog pathology: a platform for validation studies.

Authors:  Brandon D Gallas; Marios A Gavrielides; Catherine M Conway; Adam Ivansky; Tyler C Keay; Wei-Chung Cheng; Jason Hipp; Stephen M Hewitt
Journal:  J Med Imaging (Bellingham)       Date:  2014-11-12

7.  Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.

Authors:  Ponlapat Yonglitthipagon; Chawalit Pairojkul; Yaovalux Chamgramol; Alex Loukas; Jason Mulvenna; Jeffrey Bethony; Vajarabhongsa Bhudhisawasdi; Banchob Sripa
Journal:  Hum Pathol       Date:  2012-03-24       Impact factor: 3.466

8.  Progesterone Receptor Status Predicts Response to Progestin Therapy in Endometriosis.

Authors:  Valerie A Flores; Arne Vanhie; Tran Dang; Hugh S Taylor
Journal:  J Clin Endocrinol Metab       Date:  2018-12-01       Impact factor: 5.958

9.  Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer.

Authors:  Pei Li; Jian-Xiang Shi; Li-Ping Dai; Yu-Rong Chai; Hong-Fei Zhang; Mutombo Kankonde; Peggy Kankonde; Bao-Fa Yu; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

10.  Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement.

Authors:  C S Foster; A R Dodson; L Ambroisine; G Fisher; H Møller; J Clark; G Attard; J De-Bono; P Scardino; V E Reuter; C S Cooper; D M Berney; J Cuzick
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.